PEOPLE - Angiotech Pharmaceuticals (Canada) makes appointment:
This article was originally published in Clinica
Executive Summary
Canadian medical device coatings and therapy company Angiotech Pharmaceuticals (Vancouver) has appointed Rui Avelar as vice-president of investor relations and communications. Dr Avelar most recently served as biotechnology analyst and venture capital technical analyst for Haywood Securities.